JP2009535306A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535306A5
JP2009535306A5 JP2009506790A JP2009506790A JP2009535306A5 JP 2009535306 A5 JP2009535306 A5 JP 2009535306A5 JP 2009506790 A JP2009506790 A JP 2009506790A JP 2009506790 A JP2009506790 A JP 2009506790A JP 2009535306 A5 JP2009535306 A5 JP 2009535306A5
Authority
JP
Japan
Prior art keywords
variable region
region polypeptide
homology
vaccine
aiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009506790A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535306A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/067069 external-priority patent/WO2008060669A2/en
Publication of JP2009535306A publication Critical patent/JP2009535306A/ja
Publication of JP2009535306A5 publication Critical patent/JP2009535306A5/ja
Pending legal-status Critical Current

Links

JP2009506790A 2006-04-21 2007-04-20 鳥インフルエンザに対するワクチンおよび使用方法 Pending JP2009535306A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79380406P 2006-04-21 2006-04-21
PCT/US2007/067069 WO2008060669A2 (en) 2006-04-21 2007-04-20 Vaccine for avian influenza and methods of use

Publications (2)

Publication Number Publication Date
JP2009535306A JP2009535306A (ja) 2009-10-01
JP2009535306A5 true JP2009535306A5 (enExample) 2010-06-03

Family

ID=39402309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009506790A Pending JP2009535306A (ja) 2006-04-21 2007-04-20 鳥インフルエンザに対するワクチンおよび使用方法

Country Status (9)

Country Link
US (1) US7993655B2 (enExample)
EP (1) EP2010210A4 (enExample)
JP (1) JP2009535306A (enExample)
KR (1) KR20080109094A (enExample)
CN (1) CN101578111A (enExample)
AR (1) AR060565A1 (enExample)
BR (1) BRPI0710689A2 (enExample)
CA (1) CA2650091A1 (enExample)
WO (1) WO2008060669A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009540801A (ja) * 2006-06-16 2009-11-26 ダウ・アグロサイエンス・エル・エル・シー トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質
US8050871B2 (en) 2006-10-24 2011-11-01 Samuel Bogoch Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus
KR20100006574A (ko) 2007-05-30 2010-01-19 사무엘 보고치 수산 양식되는 무척추동물의 병원체 감염에 대항하는 합성 레플리킨 펩티드
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
NZ587108A (en) 2007-11-27 2013-04-26 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
SG187500A1 (en) * 2008-01-21 2013-02-28 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
DK2294202T3 (en) 2008-07-08 2015-08-31 Medicago Inc SOLUBLE RECOMBINANT INFLUENZA ANTIGENES
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
SG10201401532PA (en) * 2009-04-23 2014-08-28 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
SI2445928T1 (en) 2009-06-24 2018-05-31 Medicago Inc. HYPER PARTICULARS, SIMILAR VIRUSES OF GRIPE, WHICH HAVE EXPOSED HEMAGLUTININE
SG178918A1 (en) 2009-09-22 2012-04-27 Medicago Inc Method of preparing plant-derived vlps
EP2515661A4 (en) * 2009-12-23 2013-11-13 Vaxgene Corp IMMUNE PROTECTION THROUGH ORAL ADMINISTRATION OF MINI-CAPSULES WITH RECOMBINANT LACTOCOCCUS LACTIS
EP2563389B1 (en) 2010-04-30 2015-07-08 Temasek Life Sciences Laboratory Limited Universal vaccine against h5n1 lineages
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
WO2013013075A2 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
AU2013204906B2 (en) * 2012-03-12 2016-01-07 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
AU2013359146B2 (en) 2012-12-13 2017-12-07 Corteva Agriscience Llc DNA detection methods for site specific nuclease activity

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885248A (en) 1984-02-15 1989-12-05 Lubrizol Genetics, Inc. Transfer vector
US5173410A (en) 1984-02-15 1992-12-22 Lubrizol Genetics Inc. Transfer vector
CA1288073C (en) 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
ATE108828T1 (de) 1987-02-09 1994-08-15 Lubrizol Genetics Inc Hybrides rns-virus.
WO1991009957A1 (en) 1989-12-22 1991-07-11 E.I. Du Pont De Nemours And Company Site-specific recombination of dna in plant cells
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
JPH07200893A (ja) 1993-12-27 1995-08-04 Toshiba Corp 自動精算機
GB9615794D0 (en) * 1996-07-26 1996-09-04 Medical Res Council Mutant herpes simplex virus strains and uses thereof
US5916879A (en) * 1996-11-12 1999-06-29 St. Jude Children's Research Hospital DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof
JP2000253876A (ja) * 1999-03-08 2000-09-19 Dnavec Research Inc センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
CA2406947A1 (en) * 2000-04-19 2001-10-25 Johns Hopkins University Methods for prevention and treatment of gastrointestinal disorders
US6855536B2 (en) 2000-07-20 2005-02-15 University Of Tennessee Research Corp., Inc. Materials and methods for the enhancement of effective root nodulation in legumes
DE10049587A1 (de) 2000-10-06 2002-05-02 Icon Genetics Ag Vektorsystem für Pflanzen
DE10061150A1 (de) 2000-12-08 2002-06-13 Icon Genetics Ag Verfahren und Vektoren zur Erzeugung von transgenen Pflanzen
DE10109354A1 (de) 2001-02-27 2002-09-05 Icon Genetics Ag Rekombinante virale Schaltersysteme
DE10121283B4 (de) 2001-04-30 2011-08-11 Icon Genetics GmbH, 80333 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen
CN1533438A (zh) 2001-06-08 2004-09-29 �����Ŵ��Ƽ���˾ 在植物生产蛋白质的方法
DE10129010A1 (de) 2001-06-13 2002-12-19 Icon Genetics Ag Verfahren und Vektoren zur Erzeugung von transgenen Pflanzen
DE10143205A1 (de) 2001-09-04 2003-03-20 Icon Genetics Ag Verfahren zur Proteinproduktion in Pflanzen
ES2329450T3 (es) 2002-04-29 2009-11-26 Icon Genetics Gmbh Proceso para producir organismos transgenicos ambientalmente seguros.
NZ542933A (en) * 2003-05-05 2009-08-28 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
AU2004235813B2 (en) * 2003-05-05 2010-07-29 Boyce Thompson Institute For Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
WO2005018539A2 (en) 2003-06-16 2005-03-03 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
DE602004027403D1 (de) 2003-11-10 2010-07-08 Icon Genetics Ag Von rna-virus abgeleitetes pflanzenexpressionssystem

Similar Documents

Publication Publication Date Title
Jazayeri et al. Development of universal influenza vaccines targeting conserved viral proteins
JP2016539946A5 (enExample)
JP2009526526A5 (enExample)
JP2009540801A5 (enExample)
IL253187B (en) New vaccines based on multivalent nanoparticles
JP2012511579A5 (enExample)
PH12021550030A1 (en) Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereof
NZ701881A (en) Vaccines for hsv-2
JP2014523878A5 (enExample)
EP3494989A1 (en) Composite antigenic sequences and vaccines
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
EP2552490A4 (en) INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF
JP2015517304A5 (enExample)
Rak et al. Nucleoprotein as a promising antigen for broadly protective influenza vaccines
Shoji et al. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants
KR102180774B1 (ko) H5N8형 재조합 인플루엔자 A 바이러스 및 이를 포함하는 clade 2.3.4.4A에 속하는 H5 혈청형 인플루엔자 A 바이러스에 대한 백신 조성물
JP2014139185A5 (enExample)
RU2014140731A (ru) Варианты гемагглютинина и нейраминидазы гриппа
JP2013515490A5 (enExample)
CN113603754B (zh) 一种水禽h5n8亚型流感病毒ha重组蛋白及其制备方法与应用
Su et al. Emergence and pandemic potential of avian influenza a (H7N9) virus
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
JP2018525028A5 (enExample)
CN101857872A (zh) 甲型流感病毒抗原决定区更换方法
Hajam et al. Oral immunization with an attenuated Salmonella Gallinarum encoding the H9N2 haemagglutinin and M2 ectodomain induces protective immune responses against H9N2 infection in chickens